Here's Why Athersys Is Soaring Today

Here's Why Athersys Is Soaring Today

Source: 
Motley Fool
snippet: 

Shares of Athersys (NASDAQ:ATHX) jumped more than 18% today after the company announced that a collaboration partner has enrolled the first patient in a clinical trial in Japan. Healios is evaluating a product derived from MultiStem, the novel stem cell platform developed by Athersys, as a potential treatment for pneumonia-induced acute respiratory distress syndrome (ARDS).